JPET

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sabordo, L.
Right arrow Articles by Nation, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sabordo, L.
Right arrow Articles by Nation, R. L.

Vol. 288, Issue 2, 414-420, February 1999

Hepatic Disposition of the Acyl Glucuronide1-O-Gemfibrozil-beta -D-Glucuronide: Effects of Dibromosulfophthalein on Membrane Transport and Aglycone Formation1

Lucia Sabordo, Benedetta C. Sallustio, Allan M. Evans and Roger L. Nation

Department of Clinical Pharmacology, The Queen Elizabeth Hospital, Woodville, South Australia and Department of Clinical and Experimental Pharmacology, The University of Adelaide, Adelaide, South Australia (L.S., B.C.S.); and Centre for Pharmaceutical Research, School of Pharmacy and Medical Sciences, University of South Australia, Adelaide, South Australia (A.M.E., R.L.N.)

The liver plays an important role in the disposition of acyl glucuronides by determining their extent of formation, biliary excretion, and efflux into blood. Thus, both intrahepatic and extrahepatic exposure to these reactive polar conjugates depends on the efficiency of hepatic transport mechanisms, which may be shared with other nonbile acid organic anions. Using the isolated perfused rat liver preparation, the hepatic disposition of the acyl glucuronide, 1-O-gemfibrozil-beta -D-glucuronide, was examined in the presence of the organic anion dibromosulfophthalein (DBSP). Using a recirculating system, livers were perfused for 90 min with an erythrocyte-free perfusion medium containing 1% (w/v) albumin and 1-O-gemfibrozil-beta -D-glucuronide (3 µM) alone (n = 6) or with DBSP (200 µM, n = 7). The glucuronide was avidly taken up by the liver, excreted into bile, and hydrolyzed within the liver to its aglycone, gemfibrozil. DBSP significantly (P < .05) lowered the conjugate's mean hepatic clearance (8.98-5.17 ml/min), intrinsic clearance (44.0-17.7 ml/min), and fraction eliminated in bile (72.8-48.7% of the dose), while increasing perfusate gemfibrozil concentrations (0.52-0.92 µM at 90 min). Furthermore, DBSP significantly (P < .05) lowered the ratio of intrahepatic to unbound perfusate concentrations of 1-O-gemfibrozil-beta -D-glucuronide (139.0-35.0) and showed a trend to lower the ratio of bile to intrahepatic concentrations (111.3-76.2, P = .05). Thus, the study demonstrated that DBSP inhibited both the sinusoidal uptake and canalicular transport of 1-O-gemfibrozil-beta -D-glucuronide, suggesting that the hepatic membrane transport of acyl glucuronides is carrier mediated and shared with other organic anions.


0022-3565/99/2882-0414$03.00/0
THE JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Copyright © 1999 by The American Society for Pharmacology and Experimental Therapeutics



This article has been cited by other articles:


Home page
J. Pharmacol. Exp. Ther.Home page
Y. Shitara, M. Hirano, H. Sato, and Y. Sugiyama
Gemfibrozil and Its Glucuronide Inhibit the Organic Anion Transporting Polypeptide 2 (OATP2/OATP1B1:SLC21A6)-Mediated Hepatic Uptake and CYP2C8-Mediated Metabolism of Cerivastatin: Analysis of the Mechanism of the Clinically Relevant Drug-Drug Interaction between Cerivastatin and Gemfibrozil
J. Pharmacol. Exp. Ther., October 1, 2004; 311(1): 228 - 236.
[Abstract] [Full Text] [PDF]


Home page
Drug Metab. Dispos.Home page
B. C. Sallustio and F. L. Holbrook
In Vivo Perturbation of Rat Hepatocyte Canalicular Membrane Function by Diclofenac
Drug Metab. Dispos., December 1, 2001; 29(12): 1535 - 1538.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
L. Sabordo, B. C. Sallustio, A. M. Evans, and R. L. Nation
Hepatic Disposition of the Acyl Glucuronide 1-O-Gemfibrozil-beta -D-glucuronide: Effects of Clofibric Acid, Acetaminophen, and Acetaminophen Glucuronide
J. Pharmacol. Exp. Ther., October 1, 2000; 295(1): 44 - 50.
[Abstract] [Full Text]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1999 by the American Society for Pharmacology and Experimental Therapeutics.